You are here

Bionomics

Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%

BioSpace

Fri, 09/29/23 - 10:12 am

clinical trials

Bionomics' lead asset fails to reduce public speaking anxiety in phase 2 trials

Fierce Biotech

Mon, 12/19/22 - 11:10 am

clinical trials

public speaking anxiety

Merck targets Alzheimer's in $526M collaboration on new cognitive treatment

Fierce Pharma

Wed, 06/25/14 - 07:47 am

Alzheimer's disease

Bionomics signs option and license agreement with Merck

Fly On The Wall

Wed, 07/31/13 - 09:02 am

pain management

neuropathic pain